Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Chem Pharm Bull (Tokyo) ; 62(3): 229-37, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24583777

RESUMO

Compounds with a medium-sized flexible ring often show atropisomerism that is caused by the high-energy barriers between long-lived conformers that can be isolated and often have different biological properties to each other. In this study, the frequency of the transition between the two stable conformers, aS and aR, of thienotriazolodiazepine compounds with flexible 7-membered rings was estimated computationally by Monte Carlo (MC) simulations and validated experimentally by NMR experiments. To estimate the energy barriers for transitions as precisely as possible, the potential energy (PE) surfaces used in the MC simulations were calculated by molecular orbital (MO) methods. To accomplish the MC simulations with the MO-based PE surfaces in a practical central processing unit (CPU) time, the MO-based PE of each conformer was pre-calculated and stored before the MC simulations, and then only referred to during the MC simulations. The activation energies for transitions calculated by the MC simulations agreed well with the experimental ΔG determined by the NMR experiments. The analysis of the transition trajectories of the MC simulations revealed that the transition occurred not only through the transition states, but also through many different transition paths. Our computational methods gave us quantitative estimates of atropisomerism of the thienotriazolodiazepine compounds in a practical period of time, and the method could be applicable for other slow-dynamics phenomena that cannot be investigated by other atomistic simulations.


Assuntos
Azepinas/química , Método de Monte Carlo , Teoria Quântica , Triazóis/química , Espectroscopia de Ressonância Magnética , Estereoisomerismo
2.
ACS Med Chem Lett ; 4(11): 1059-63, 2013 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-24900605

RESUMO

A facile methodology effective in obtaining a set of compounds monofluorinated at various positions (fluorine scan) by chemical synthesis is reported. Direct and nonselective fluorination reactions of our lead compound 1a and key intermediate 2a worked efficiently to afford a total of six monofluorinated derivatives. All of the derivatives kept their physicochemical properties compared with the lead 1a and one of them had enhanced Raf/MEK inhibitory activity. Keeping physicochemical properties could be considered a benefit of monofluorinated derivatives compared with chlorinated derivatives, iodinated derivatives, methylated derivatives, etc. This key finding led to the identification of compound 14d, which had potent tumor growth inhibition in a xenograft model, excellent PK profiles in three animal species, and no critical toxicity.

3.
Bioorg Med Chem Lett ; 19(10): 2772-6, 2009 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-19362835

RESUMO

CH0793076 (1) is a novel hexacyclic camptothecin analog showing potent antitumor activity in various human caner xenograft models. To improve the water solubility of 1, water-soluble prodrugs were designed to generate an active drug 1 nonenzymatically, thus expected to show less interpatient PK variability than CPT-11. Among the prodrugs synthesized, 4c (TP300, hydrochloride) having a glycylsarcosyl ester at the C-20 position of 1 is highly water-soluble (>10mg/ml), stable below pH 4 and rapidly generates 1 at physiological pH in vitro. The rapid (ca. <1min) generation of 1 after incubation of TP300 with plasma (mouse, rat, dog and monkey) was also demonstrated. TP300 showed a broader antitumor spectrum and more potent antitumor activity than CPT-11 in various human cancer xenograft models.


Assuntos
Antineoplásicos/síntese química , Camptotecina/análogos & derivados , Pró-Fármacos/síntese química , Animais , Antineoplásicos/sangue , Antineoplásicos/farmacocinética , Camptotecina/sangue , Camptotecina/síntese química , Camptotecina/química , Camptotecina/farmacocinética , DNA Topoisomerases Tipo I/metabolismo , Cães , Haplorrinos , Humanos , Concentração de Íons de Hidrogênio , Irinotecano , Camundongos , Camundongos Nus , Pró-Fármacos/química , Pró-Fármacos/farmacocinética , Ratos , Inibidores da Topoisomerase I , Transplante Heterólogo , Água/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...